Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Software Maker Endava Beats Estimates, Reiterated as a Top Idea at Citi

Published 09/28/2022, 07:05 AM
Updated 09/28/2022, 07:18 AM
© Reuters.  Software Maker Endava (DAVA) Beats Estimates, Reiterated as a Top Idea at Citi
DAVA
-

By Senad Karaahmetovic

Endava (NYSE:DAVA) reported earnings that came in ahead of market expectations, although its shares trade over 2% lower in London today.

Endava reported a Q4 EPS of £0.51, better than the analyst estimate of £0.49. Revenue for the quarter came in at £180.4 million, which is again better than the consensus estimate of £178.35 million.

For this quarter, the company sees EPS between £0.50 and £0.51, lower than the consensus of £0.54. Revenue is seen in the £191 million-193 million range, better than the consensus of £180 million.

For the full year, DAVA is calling for an adjusted EPS of £2.365 on sales of £845 million - midpoints of both ranges - while analysts were calling for £2.33 on revenue of £823.9 million.

"Endava's strong results for Q4FY2022 and for the full FY2022 are the result of continued solid demand for our digital acceleration services across all regions and verticals, despite headwinds from continued global macro uncertainty and volatility," said John Cotterell, Endava's CEO.

A Citi analyst lowered the price target on DAVA to $110 per share from the prior $145 but remains positive amid “robust demand.” The analyst continues to see DAVA as one of the top IT Services ideas.

“The FY23 constant currency growth outlook likely came in below expectations but we still view this 23%-24% range as relatively solid given the macro uncertainty that has arisen since last earnings (last reported mid-May). Although the demand environment remains strong and Endava has not yet seen any negative impacts from the macro, it still included some macro conservatism in the outlook (particularly in fiscal 2H23 as visibility naturally decreases),” he told clients.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

A Morgan Stanley analyst also cut the price target as he went to $95 from $130 on Overweight-rated DAVA shares.

“Despite minor signs of macro impact, demand appears durable with acceleration in spend at certain clients offsetting minor delays at others. We appreciate management’s prudent conservatism in its FY23 outlook and remain mindful of potential demand shifts as supply trends appear to be normalizing,” the analyst wrote.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.